BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation
- 21 February 2005
- journal article
- Published by Springer Nature in Oncogene
- Vol. 24 (20), 3285-3296
- https://doi.org/10.1038/sj.onc.1208492
Abstract
Germline mutations in the BRCA1 gene are associated with an increased susceptibility to the development of breast and ovarian cancers. Evidence suggests that BRCA1 protein plays a key role in mediating DNA damage-induced checkpoint responses. Several studies have shown that ectopic expression of BRCA1 in human cells can trigger cellular responses similar to those induced by DNA damage, including G2/M cell cycle arrest and apoptosis. While the effects of ectopic BRCA1 expression on the G2/M transition and apoptosis have been extensively studied, the factors that dictate the balance between these two responses remain poorly understood. We have recently shown that ectopic expression of BRCA1 in MCF-7 human breast cancer cells resulted in activation of extracellular signal-regulated protein kinase 1 and 2 (ERK1/2) and G2/M cell cycle arrest. Furthermore, inhibition of BRCA1-induced ERK1/2 activation using mitogen-activated protein kinase kinase 1 and 2 (MEK1/2)-specific inhibitors resulted in increased apoptosis, suggesting a potential role of ERK1/2 kinases in BRCA1-mediated G2/M checkpoint response. In this study, we assessed the role of ERK1/2 kinases in the regulation of BRCA1-mediated G2/M cell cycle arrest. Results indicate that BRCA1-induced G2/M cell cycle arrest and ERK1/2 activation correlate with changes in the level and/or activity of several key regulators of the G2/M checkpoint, including activation of Chk1 and Wee1 kinases, induction of 14-3-3, and down-regulation of Cdc25C. Furthermore, inhibition of ERK1/2 kinases using MEK1/2-specific inhibitors results in a marked attenuation of the BRCA1-induced G2/M arrest. Biochemical studies established that ERK1/2 inhibition abolished the effects of BRCA1 on components of the G2/M checkpoint, including regulation of Cdc25C expression and activation of Wee1 and Chk1 kinases. These results implicate a critical role of ERK1/2 signaling in the regulation of BRCA1 function on controlling the G2/M checkpoint responses.Keywords
This publication has 47 references indexed in Scilit:
- MAPK pathways in radiation responsesOncogene, 2003
- BRCA1-induced Apoptosis Involves Inactivation of ERK1/2 ActivitiesPublished by Elsevier ,2002
- BRCA1 Directs a Selective p53-Dependent Transcriptional Response towards Growth Arrest and DNA Repair TargetsMolecular and Cellular Biology, 2002
- BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damageNature Genetics, 2002
- Roles of BRCA1 and its interacting proteinsBioEssays, 2000
- Centrosome Amplification and a Defective G2–M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform–Deficient CellsMolecular Cell, 1999
- Mitogen-activated protein kinase pathwaysCurrent Opinion in Cell Biology, 1997
- Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.Genes & Development, 1997
- PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinaseNature, 1994
- Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cellsCell, 1994